tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Enlivex Therapeutics Ltd (ENLV)
NASDAQ:ENLV
US Market
ENLV
Enlivex
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Enlivex (ENLV) Stock News & Sentiment

Compare
454 Followers
Promising Potential of Enlivex’s Allocetra in Osteoarthritis: Buy Rating with $7 Price Target
Premium
Ratings
Promising Potential of Enlivex’s Allocetra in Osteoarthritis: Buy Rating with $7 Price Target
4d ago
ENLV
Enlivex Reports Financial Results for Mid-2025
Premium
Company Announcements
Enlivex Reports Financial Results for Mid-2025
8d ago
6K
ENLV
Enlivex’s Allocetra: A New Hope for Psoriatic Arthritis?
Premium
Company Announcements
Enlivex’s Allocetra: A New Hope for Psoriatic Arthritis?
17d ago
ENLV
Enlivex Therapeutics’ Phase 2 Study on Allocetra-OTS for Sepsis: Key Insights for Investors
Premium
Company Announcements
Enlivex Therapeutics’ Phase 2 Study on Allocetra-OTS for Sepsis: Key Insights for Investors
17d ago
ENLV
Enlivex Therapeutics’ Phase 2 Study on Allocetra-OTS: A Promising Update for Sepsis Treatment
Premium
Company Announcements
Enlivex Therapeutics’ Phase 2 Study on Allocetra-OTS: A Promising Update for Sepsis Treatment
18d ago
ENLV
Enlivex Therapeutics Advances Psoriatic Arthritis Treatment with Allocetra Study
Premium
Company Announcements
Enlivex Therapeutics Advances Psoriatic Arthritis Treatment with Allocetra Study
18d ago
ENLV
Enlivex Announces Promising Phase IIa Results for Allocetra in Knee Osteoarthritis
Premium
Company Announcements
Enlivex Announces Promising Phase IIa Results for Allocetra in Knee Osteoarthritis
19d ago
6K
ENLV
More ENLV News >

ENLV News on the Web

Enlivex to Present Key Results from Osteoarthritis Trial
TipRanks News
Neutral
Enlivex Completes Phase II Enrollment for Osteoarthritis Trial
TipRanks News
Neutral
Enlivex Therapeutics Releases 2024 Financial Statements
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Harvard Bioscience (HBIO) and Enlivex (ENLV)
TipRanks News
Neutral
Enlivex Reports Promising Interim Results in Osteoarthritis Trial
TipRanks News
Neutral
Enlivex Reports Promising Interim Results in Knee Osteoarthritis Trial
TipRanks News
Neutral
Enlivex Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis
Yahoo Finance
Neutral
Enlivex Therapeutics Starts Phase II Allocetra Trail to Treat Knee Osteoarthritis
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ENLV
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ENLV’s Media Buzz Sentiment?
Currently, no data Available
What is ENLV’s weekly average amount of articles?
Currently, no data Available
What is ENLV’s News Sentiment?
59% of articles about ENLV were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    HALOHalozyme
    UTHRUnited Therapeutics
    KNSAKiniksa Pharmaceuticals
    PHRPhreesia
    PNTGPennant Group
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing